Global Pharmaceutical and Biopharmaceutical Safety Testing Service Market 2023 by Company, Regions, Type and Application, Forecast to 2029
According to our (Global Info Research) latest study, the global Pharmaceutical and Biopharmaceutical Safety Testing Service market size was valued at USD 3683.6 million in 2022 and is forecast to a readjusted size of USD 7743.3 million by 2029 with a CAGR of 11.2% during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Biosafety testing is a series of assays to evaluate the potential biological risks of new biological products, including viral testing, microbial testing, cell and molecular testing, and analytic testing. Health authorities such as the European Medicines Agency (EMA) and the US Food and Drug Administration (FDA) require all biopharmaceutical products and vaccines to undergo stringent testing to ensure the product is safe and free of contaminants.
This report is a detailed and comprehensive analysis for global Pharmaceutical and Biopharmaceutical Safety Testing Service market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Pharmaceutical and Biopharmaceutical Safety Testing Service market size and forecasts, in consumption value ($ Million), 2018-2029
Global Pharmaceutical and Biopharmaceutical Safety Testing Service market size and forecasts by region and country, in consumption value ($ Million), 2018-2029
Global Pharmaceutical and Biopharmaceutical Safety Testing Service market size and forecasts, by Type and by Application, in consumption value ($ Million), 2018-2029
Global Pharmaceutical and Biopharmaceutical Safety Testing Service market shares of main players, in revenue ($ Million), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Pharmaceutical and Biopharmaceutical Safety Testing Service
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Pharmaceutical and Biopharmaceutical Safety Testing Service market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Merck, Charles River Laboratories, Sartorius, Eurofins Scientific and SGS, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market segmentation
Pharmaceutical and Biopharmaceutical Safety Testing Service market is split by Type and by Application. For the period 2018-2029, the growth among segments provide accurate calculations and forecasts for consumption value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Raw Materials
Viral Banks
Cell Banks
Others
Market segment by Application
Pharmaceutical and Biotechnology Companies
CROs and CDMOs
Academic and Research Institutions
Market segment by players, this report covers
Merck
Charles River Laboratories
Sartorius
Eurofins Scientific
SGS
Q2 Solutions
Samsung Biologics
Texcell
WuXi Biologics
Wuhan Canvest Biotechnology
Centre Testing International (CTI)
Suzhou Liangchen Biotechnology
JADE Biomedical
Standard Testing Group
Sino Tech World Biologicals
CAS Testing Technical Services
NTEK
Sino Biological
Miracle Points
Suzhou Cefety Bioscience
Zhejiang Hengyu Biological
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
South America (Brazil, Argentina and Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Pharmaceutical and Biopharmaceutical Safety Testing Service product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Pharmaceutical and Biopharmaceutical Safety Testing Service, with revenue, gross margin and global market share of Pharmaceutical and Biopharmaceutical Safety Testing Service from 2018 to 2023.
Chapter 3, the Pharmaceutical and Biopharmaceutical Safety Testing Service competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2018 to 2029.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2018 to 2023.and Pharmaceutical and Biopharmaceutical Safety Testing Service market forecast, by regions, type and application, with consumption value, from 2024 to 2029.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War
Chapter 12, the key raw materials and key suppliers, and industry chain of Pharmaceutical and Biopharmaceutical Safety Testing Service.
Chapter 13, to describe Pharmaceutical and Biopharmaceutical Safety Testing Service research findings and conclusion.